Session Information
ENDO 2011 Annual Meeting
Click here to go to the previous page
Managing CV Risk in Type 2 Diabetes
Track : CLINICAL
Program Code: M17
Date: Sunday, June 5, 2011
Time: 8:30 AM to 9:15 AM  EST
Location: 153ABC
SPEAKER :
Samuel Dagogo-Jack, MD,FRCP, Univ of Tennessee-Memphis
Disclosures: SD-J: Speaker, Eli Lilly & Company, GlaxoSmithKline; Consultant, Merck & Co., Roche Pharmaceuticals; Principal Investigator, Astra Zeneca, Bristol-Myers Squibb.


Audio Synchronized to PowerPoint
(Code: M17)
Attendee/Member-in-Training:
Attendee/Member:
Attendee/Non-Member:
Non-Attendee/Member-in-Training:
Non-Attendee/Member:
  
This session is a part of: